The literature reveals what little is known about nutritional factors and hair loss. What we do know emanates from studies in protein-energy malnutrition, starvation, and eating disorders. In otherwise healthy individuals, nutritional factors appear to play a role in subjects with persistent increased hair shedding. Hård, 40 years ago, demonstrated the importance of iron supplements in nonanaemic, iron-deficient women with hair loss. Serum ferritin concentrations provide a good assessment of an individual's iron status. Rushton et al. first published data showing that serum ferritin concentrations were a factor in female hair loss and, 10 years later, Kantor et al. confirmed this association. What level of serum ferritin to employ in subjects with increased hair shedding is yet to be definitively established but 70 lg ⁄ L, with a normal erythrocyte sedimentation rate (< 10 mm ⁄ h), is recommended. The role of the essential amino acid, L-lysine in hair loss also appears to be important. Double-blind data confirmed the findings of an open study in women with increased hair shedding, where a significant proportion responded to L-lysine and iron therapy. There is no evidence to support the popular view that low serum zinc concentrations cause hair loss. Excessive intakes of nutritional supplements may actually cause hair loss and are not recommended in the absence of a proven deficiency. While nutritional factors affect the hair directly, one should not forget that they also affect the skin. In the management of subjects with hair loss, eliminating scaling problems is important as is good hair care advice and the need to explain fully the hair cycle. Many individuals reduced their shampooing frequency due to fear of losing more hair but this increases the amount seen in subsequent shampoos fuelling their fear of going bald and adversely affecting their quality of life.
Introduction
The literature reveals what little is known about nutritional factors in hair loss in otherwise healthy individuals. It was therefore no surprise to learn that most medical students have little or no knowledge of the role of nutrition in skin diseases, even where there is a proven nutritional basis; acrodermatitis enteropathica. 1 Except in severe malnutrition 2 starvation and the eating disorders anorexia and bulimia nervosa 3 even less is known about the effect of nutrition in hair loss. Fortunately the vast majority of patients seeing their general practitioner or dermatologist will in all probability have no recognized illness and a nutritional basis for their hair loss should be considered.
Animal coats are not only functionally important but also fundamental for signalling (i.e. aggression) and a loss of fur could have serious consequences for survival. In humans, the loss of scalp or body hair is non lifethreatening; neither is it of any significance for survival. It can however, adversely affect an individual's quality of life. 4 The integrity of normal skin and hair function relies largely on an adequate and balanced nutritional intake. Dietary imbalance, whether in the form of an overall deficiency, specific shortage, excess of one component over another, can disturb this equilibrium.
In animals nutritional factors and hair loss have been reported over the past 70 years. Cunningham in 1932 noted hair loss in iron deficient rats 5 while in 1941 Sullivan and Nicholls 6 found hair loss in rats deficient in riboflavin. Hair loss in both rats 7 and mice 8 has been reported due to zinc deficiency. It has long been recognized that diet influences the coat of animals and while the affect of poor grazing and low fleece weight have been known for many years 9 just how poor nutrition effects fur, hair and wool growth is not fully understood. In 1954 Van Koetsveld 10 reviewed the influence of feeding on the animal coat, while Flesch 11 briefly reviewed the effect of diet on hair growth. Yet despite unlimited grazing or a variety of special feeds, which have been shown to increase the hard keratin composition of wool in sheep, the amount and composition of wool that can ultimately grow is genetically controlled. 12 The influence of proteins, carbohydrates, fats, minerals, and vitamins in various animals is reviewed by Ryder 9 and worth reading for those wanting a historical perspective.
In humans, the association of nutrition with skin and hair changes emanates primarily from studies on protein-energy malnutrition. 2, 13 Hair root response to protein malnutrition has been studied widely in children with kwashiokor, marasmus, and marasmic-kwashiokor conditions and reviewed comprehensively by Bradfield and Bailey; 14 the hair is easily epilated, finer in diameter; less curly, depigmented, breaks off, falls out, and has a lower daily rate of growth. 15 There are also notable changes in skin keratinization, hyper-and hypopigmentation, and delayed wound healing. Hughes 16 reported not only hair loss and hypopigmentation but loss of hair curl in African children following pantothenic acid and riboflavin deficiency.
According to Stewart and Gutherie 17 in 1497 Vasco de Gamma recorded the deaths of 100 of his 160 sailors after scurvy had broken out during his voyage around the Cape of Good Hope. It took almost 300 years before James Lind confirmed the empirical link between scurvy and vitamin C. Of note was the fact that before death, skin haemorrhage and hair loss was observed. 17 18 More recently the beneficial role of vitamin D analogues in psoriasis has been established. 19 Other examples of dietary affects on skin are nicotinic acid and thiamine to name two, but whether there is a link with hair loss is unknown.
It took many years after the initial clinical observations for a link with a nutritional deficiency to be confirmed. The discovery and identification of vitamins played a critical role in the evolution of nutritional medicine. In 1912 vitamin A was the first vitamin to be described and over the next 36 years the remaining vitamins were isolated and identified, vitamins D, E, C, B 1 , B 2 , pantothenic acid, biotin, vitamins K, B 6 , niacin, folic acid and finally, in 1948 vitamin B 12 . 20 As in animals, nutritional influences in humans can affect the skin and cause scaling maladies resulting in excessive hair shedding. It is important therefore to separate those nutritional factors that act directly on the skin, from those acting only on the hair follicle.
Scaling problems and hair loss: is there a nutritional basis?
It has long been recognized that some chronic scaling conditions of the scalp lead to increased hair shedding (telogen effluvium) and a temporary reduction in hair density (hairs per cm 2 ) due to pruritus and excoriations. 21 Less recognized is the possible involvement of nutritional factors in mild to moderate scaling conditions, i.e. scaling only slightly more severe than simple dandruff, which some clinicians would term mild seborrhoeic eczema (seborrhoeic dermatitis). Usually the lesions are restricted to the scalp, nasal fold, and eyebrows. In men the beard and chest are affected if more than a scattering of hair is present. The adverse affects of dairy produce in skin diseases are not new. 22 Food allergy and food intolerances are due to hypersensitivity type I mediated reactions. There is, however, considerable debate as to whether such reactions can affect the hair cycle. Even where there is strong evidence for an immunological involvement in the skin (IgE, mast cell, etc.), much scepticism surrounds any hair follicle involvement. 23 Biotin deficiency is reported to cause dermatitis and hair loss in experimentally induced states 24, 25 but establishing the presence of a deficiency in humans with a balanced diet has yet to be demonstrated. However, 1-2 mg of biotin daily for 2 months has anecdotal clinical support in unresponsive scaling problems and may be worth consideration.
As with biotin there is good animal data to support the role of an essential fatty acid (EFA) deficiency in dermatitis and hair loss, with some limited evidence established in humans. 26, 27 Where it occurs naturally in humans, EFA deficiency is purely of dietary origin. Essential fatty acids are also known as polyunsaturated fatty acids and two groups are currently considered important: the omega-6 EFAs derived from linoleic acid and present in vegetables and red meat; and the omega-3 EFAs derived from a-linolenic acid and present in oily fish and marine animals. The ideal ratio should be 5 : 1 (linoleic : a-linolenic acid) but currently in the UK it is reported to be 12 : 1.
28 both are involved in a multitude of physiologically important pathways. Links with atopic eczema and psoriasis have been suggested but there is little firm evidence that the manipulation of dietary EFAs in other skin conditions is of any benefit. In unresponsive scaling problems it might be worth considering trying an EFA supplement if the subject's diet is low in fish oil or red meat; unfortunately, there is no routine investigation available to assess this. In psoriasis a daily supplement of fish oil (providing 18 g of EFA) led to a clinical but not statistical improvement. 29 The rational for this stems from the low frequency of psoriasis in the Eskimo but recent investigations suggest this is due to a genetic factor 30 which affects how EFAs are metabolized rather than the level of EFA consumed.
The role of zinc in the rare congenital skin disease acrodermatitis enteropathica is well known to dermatologists 1,31 though few will have ever seen an actual case in clinical practice. The clinical manifestations associated with zinc deficiency arise primarily from the cutaneous changes similar to those found in acrodermatitis enteropathica. 32 
Nutrition and hair loss without scaling problems
Possibly one of the most contentious areas in dermatology is the role of nutritional factors in scalp hair loss in subjects without any observable scaling malady. The lack of objective data is obvious and stems primarily from difficulties in being able to quantitatively evaluate scalp hair loss. Matters are further complicated in females by the historical positioning of reference ranges now shown to have been derived from populations containing a large number of iron deficient women. 33 A large number of women complain of persistent increased hair shedding (chronic telogen effluvium, CTE). Many will have sought professional help but without much success. Too often, they are dismissed because the hair loss is not obvious. 34 Men complaining with CTE are even more difficult to evaluate as during the active phase of male balding increased hair shedding is a notable clinical feature. 35 Compounding matters is the frequency of balding in men, which increases with age 36 thus potentially masking any nutritional problem that might have developed due to a dietary imbalance. Although no published data could be found for the frequency of men presenting with CTE, it should be higher in females if low iron stores turn out to be a primary cause of CTE. The percentage of balding men with a serum ferritin below 40 lg ⁄ L in 1990 was less than 4% (D. H. Rushton, unpublished data), while in women with reduced hair density it was 72%. 37 The frequency of hair loss in the general female population is unknown. In an attempt to determine how many women might be affected, females from Japan, the USA and UK were questioned about their hair status compared to 5 years earlier. The results for those aware of increased hair shedding are given in Table 1 . We were surprised to find 34% of premenopausal women reporting increased hair shedding. In an attempt to see if there was a possible link between CTE and nutritional factors, 200 women presenting with unexplained persistent hair shedding but having a normal scalp hair density, as assessed with the unit area trichogram 38 were investigated. Table 2 presents the data obtained and shows the frequency of blood variables believed to be affected by nutrition (haemoglobin, ferritin, vitamin B 12 , folic acid, and zinc), which extends the initial work of Rushton published in 1993. 39 There is widespread popular belief that zinc deficiency can cause hair loss. However, the published data shows no link at all in alopecia areata 40 or telogen effluvium. 41 In Table 2 serum Zn concentrations were below the lower limit of normal in 7%, however, when these women were treated with the essential amino acid L-lysine, only one of the 14 originally ÔdeficientÕ women required Zn supplementation (Table 3 ). This suggests that the true frequency of Zn deficiency in women with CTE in the UK is around 0.5% and much lower than previously thought. Correcting the Zn deficiency in this subject did not resolve her CTE. 
Essential amino acids
The role of essential amino acids in anaemia is well known but their possible impact on hair growth has never been investigated. This is probably due to the abundance of body stores and as with the essential fatty acids, amino acid deficiency in well-nourished individuals is unlikely. However, the rate limiting essential amino acid L-lysine is a noteworthy exception. The bioavailability of L-lysine is restricted primarily to meat, fish, and eggs; consequently reducing the consumption of these foods could result in a shortfall between uptake and utilization resulting in a negative balance. While the body could make up any shortfall from the muscle reserves, it could arguably prioritize their availability for the essential tissues leaving nonessential tissue such as scalp hair compromised.
At the present time little is known about the specific role that essential amino acids might have in hair growth and even less about their influence in trace element uptake and utilization. L-lysine appears to play a role in iron and Zn uptake. In iron deficiency without anaemia, the typical (classic) biochemical response of the haematological variables are: low haemoglobin, serum iron, percentage of iron saturation and ferritin, and a raised total iron binding capacity (Table 4) . Such individuals respond to iron supplementation, i.e. elemental Fe 50 mg twice daily; however, in some women only a modest increase in serum ferritin concentration is achieved. In these individuals there is a lower than expected total iron binding capacity, high percentage of iron saturation with a low Hb and ferritin (Table 4) . Adding the essential amino acid L-lysine (1.5-2 g ⁄ day) to their existing iron supplementation resulted in a significant (P < 0.001) increase in the mean serum ferritin concentration (Table 5) . How L-lysine affects iron uptake is unknown but is the subject of ongoing research.
What is the evidence for iron deficiency and excessive hair shedding?
The need to transport oxygen and remove carbon dioxide from animal tissue is a fundamental requirement of life, which is independent of age or sex. 42 The role of iron in humans and many other mammals is central to this process. 43, 44 In the absence of Table 2 Biochemical results obtained in 200 apparently healthy women complaining of increased hair shedding for longer than 6 months (CTE). 
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For a serum ferritin of 70 lg ⁄ L. S, Serum; TIBC, total iron binding capacity. inflammatory disease, it is well established that serum ferritin is a good indicator of body iron stores. 45 Cunningham in 1932 noted hair loss in iron deficient rats 5 and in 1963 Hård 46 first demonstrated the role of iron as an aetiological factor in diffuse hair loss in nonanaemic, iron deficient women. However, the role of iron in hair loss is still the subject of much debate with those against citing the fact that some women with iron deficiency or iron deficiency anaemia do not complain of telogen effluvium. While this may be true these individuals do not present to the dermatologist complaining of hair loss! Perhaps we need to consider individuals with hair loss a subpopulation and, thus, blood parameters employed for those without hair loss are inappropriate.
The evidence for this can be found in Table 2 , which shows the most frequent abnormal nutrient in women presenting with CTE is a low serum ferritin. Sixty-five per cent had a concentration below 40 lg ⁄ L the lowest control value obtained in women without hair loss 37 a level just above the lower limit of normal for males quoted in some laboratories. 34 However 96% had a serum ferritin below 70 lg ⁄ L, the upper 99% confidence limit for iron staining in the bone marrow. 45 Low serum ferritin concentrations in women with hair loss have recently been reported by Kantor et al. 47 supporting the initial observation of Rushton in 1993. 39 In 22 women with CTE, Rushton et al. 48 demonstrated a significant (P < 0.0001) decrease in the percentage of hair in the telogen phase after 6 months' treatment with a daily iron (Fe 72 mg) and L-lysine (1.5 g) supplement. Compared to baseline, this represented a mean percentage decrease in hair shedding of 39%. In addition, a significant (P < 0.0001) increase in the mean serum ferritin level also occurred (Table 6 ). To confirm these findings a double-blind, placebo controlled study was undertaken using the same iron and lysine regimen and the results obtained are presented (Table 7) . A significant (P < 0.05) increase in the mean serum ferritin concentration was found in the treated but not in the placebo group. Compared to baseline, a decrease in the percentage of hair in the telogen phase, representing a 31% reduction in the amount of hair shed was observed in treated subjects compared with a 9% increase in those receiving placebo (Fig. 1) .
Excessive supplementation
A link between excessive vitamin A intake and hair loss is well established 49 and other fat-soluble vitamins may also pose a potential problem. There is some evidence for an adverse effect on hair growth following excessive vitamin E intake, where a significant decrease in serum thyroid hormone levels was found in volunteers taking 600 IU of vitamin E per day for 28 days. While this dosage was around 30 times the daily recommend intake, 49 even higher levels appear to be well tolerated. Currently, mega-doses of vitamin E are consumed in the belief that it reduces the level of free radicals in the body. Current opinion considers vitamin E to be one of the least toxic fat-soluble vitamins. For other fat-soluble vitamins and trace elements, an association with hair * Statistical analysis: Paired Student's t-test, P < 0.001. Table 5 Changes in serum ferritin concentration in seven women with CTE who failed to respond to iron supplementation alone but subsequently responded when the essential amino acid L-lysine was co-administered. loss is not established. Even less well understood is the effect of taking excessive amounts of water-soluble vitamins, which traditionally were thought to be excreted and not stored, thus posing no toxic threat. However, while gross toxicity may not be an issue the position may need re-evaluation with regard to hair loss. Table 2 shows that a significant proportion of women with CTE had a raised serum folic acid concentration and on questioning the majority revealed that they were taking multivitamin supplements because of their hair loss. Over-the-counter preparations often contain concentrations of folic acid at the recommended daily allowance (400 lg) but clearly there appears to be no allowance for the fact that most diets contain considerable amounts of folic acid. Many multivitamin formulations fail to allow for problems arising from interactions between other elements. If the level of zinc is equal to that of iron then iron uptake is significantly decreased: a ratio of 3 : 1 (Fe : Zn) is desirable to prevent competitive interference. Whether excessive intake of relatively high doses of multivitamins or trace elements are a factor in CTE is unknown but they could pose potential problems. One should therefore be alert to patients taking excessive amounts of nutritional supplements. In such individuals elevated red cell folic acid concentrations are found where folic acid is present in their supplementation regimen. In the absence of quantitative data supporting any beneficial or detrimental affect of multivitamin or trace element supplementation, avoidance is recommended.
Nutritional consequences of hair treatment: anti-androgen therapy
Over the past 20 years women with a diffuse hair loss (androgenetic alopecia) have been treated with a combination of the oral anti-androgen, cyproterone acetate (CPA) and ethinyl oestradiol (EE 2 ) or CPA and Dianette. 50, 51 Ramsay and Rushton 52 first demonstrated an interaction between CPA and a reduction in serum vitamin B 12 concentrations. While CPA caused a significant decrease in serum vitamin B 12 concentration in all those treated, this did not adversely affect any haematological variable. 52 There was also no evidence that lower serum vitamin B 12 concentrations were associated with increased hair shedding but this has yet to be confirmed. The typical lower reference ranges for serum vitamin B 12 in the UK are between 180 and 200 ng ⁄ L. However, vitamin B 12 levels below 300 ng ⁄ L have been found to cause anxiety and neurological changes in both men and women. 53 Anxiety and depression is a frequently reported side-effect of CPA ⁄ EE 2 and oral contraceptive therapy. Barth et al. 54 reported around 20% of women taking Dianette, which contains 2 mg of CPA, or Dianette plus CPA developing depression while on treatment, unfortunately no vitamin B 12 evaluations were undertaken. In women being treated with oral CPA and EE 2 , concurrent oral vitamin B 12 supplementation (100-200 lg per day) maintained serum B 12 concentrations above 300 lg ⁄ L. 52 In the diet, vitamin B 12 is only found in meat, chicken, fish and eggs. Assessing the vitamin B 12 concentration before starting CPA therapy with subsequent followup at 4 months is advisable.
Conclusion
With the exception of iron and the essential amino acid L-lysine, in otherwise healthy individuals nutritional factors play only a minor role in patients presenting with unexplained increased hair shedding (CTE). However, in those who selectively avoid certain foods imbalances occur with adverse consequences for both skin and hair.
Hård 46 almost 40 years ago demonstrated the importance of iron supplements in nonanaemic, iron deficient women with hair loss. Rushton et al. in 1990 first published data showing that serum ferritin concentrations may be a factor in diffuse hair loss in women, fertility 55 and CTE. 39 Kantor et al. 47 ten years later confirmed the link between hair loss and low serum ferritin concentrations. The double-blind data presented confirmed the open study of Rushton et al. 48 suggesting that a significant number of women with CTE will respond positively to L-lysine and iron therapy. While independent confirmation is awaited it would seem appropriate to consider the nutritional status of women with CTE. Further, there appears to be a minimum ferritin concentration required to optimize treatments in diffuse hair loss. 51, 56 What level of serum ferritin to use is still not fully resolved but 70 lg ⁄ L, with a normal erthrocyte sedimentation rate (< 10 mm ⁄ h) is a recommended level to achieve. The level of supplementation or dietary change needed to maintain serum ferritin concentrations above 70 lg ⁄ L is the subject of continuing research. Preliminary analysis of the data suggests that daily iron supplementation of between 24 and 48 mg is needed in menstruating women, with a lower level required in postmenopausal females. Contrary to popular belief there is no evidence to support the view that a low serum Zn is involved in CTE.
While nutritional factors affect the hair directly, one should not forget that they also affect the skin. In the management of subjects with hair loss, eliminating scaling problems is important as is good hair care advice and the need to explain fully the hair cycle. Many individuals reduced their shampooing frequency due to fear of losing more hair but this just increases the amount seen in subsequent shampoos fuelling their fear of going bald and adversely affecting their quality of life.
